FDA Adverse Event Malfunction Summary report: N

BD COR¿ MX

MDR report key: 21691589 · Received March 25, 2025

Report

Report Number
1119779-2025-00215
Event Type
Malfunction
Date Received
March 25, 2025
Date of Event
March 12, 2025
Report Date
June 5, 2025
Manufacturer
BECTON DICKINSON & CO. (SPARKS)
Product Code
LSL
UDI-DI
00382904439897
PMA / PMN Number
K210585
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

D2A. DNA PROBE, NUCLEIC ACID AMPLIFICATION, CHLAMYDIA, TRICHOMONAS VAGINALIS NUCLEIC ACID AMPLIFICATION TEST SYSTEM, NUCLEIC ACID DETECTION SYSTEM FOR NON-VIRAL MICROORGANISM(S) CAUSING SEXUALLY TRANSMITTED INFECTIONS. D2B. MKZ, OUY, QEP. D.4. MEDICAL DEVICE EXPIRATION DATE: UNKNOWN. A DEVICE EVALUATION AND/OR DEVICE HISTORY REVIEW IS ANTICIPATED BUT IS NOT COMPLETE. UPON COMPLETION, A SUPPLEMENTAL REPORT WILL BE FILED.

Additional Manufacturer Narrative · 0

INVESTIGATION SUMMARY: THIS COMPLAINT ALLEGES THE BD COR MX HAD A SAMPLE THAT RECEIVED A FALSE POSITIVE RESULT FOR TV AND UNRESOLVED FOR CT/GC. IT IS THE CUSTOMER'S PROTOCOL TO REPEAT UNRESOLVED RESULTS ON THE BD MAX, WHERE A NEGATIVE WAS RECEIVED FOR ALL TESTS ON THIS SPECIMEN. NO INSTRUMENT ISSUES WERE DETECTED; THE UNIT IS FUNCTIONING CORRECTLY. A CASE HAS BEEN CREATED TO INVESTIGATE THE REAGENTS USED DURING THIS TESTING. THIS COMPLAINT IS AN UNCONFIRMED INSTRUMENT FAILURE. NO SAMPLES WERE EXPECTED TO BE RECEIVED AS PART OF THIS COMPLAINT, AND THEREFORE NO SAMPLES WERE RETURNED, AND NO RETURNED MATERIAL INVESTIGATION COULD OCCUR. DHR REVIEW IS NOT REQUIRED FOR THIS COMPLAINT AS THIS COMPLAINT DOES NOT ALLEGE AN EARLY LIFE FAILURE OR FAILURE AT INSTALLATION AND THE CONFIGURATION HAS CHANGED SINCE RELEASE FOR MANUFACTURING DUE TO SERVICE REPAIRS/PMS. SERVICE HISTORY REVIEW REVEALED THERE WAS ONE PREVIOUS COMPLAINT FOR THIS ISSUE. BD QUALITY WILL CONTINUE TO MONITOR FOR TRENDS ASSOCIATED WITH THE FAILURE MODE DESCRIBED IN THIS COMPLAINT. REVIEW OF RISK MANAGEMENT FILES CONFIRMS THERE ARE NO NEW OR MODIFIED RISKS ASSOCIATED WITH THIS FAILURE MODE.

Description of Event or Problem · 0

IT WAS REPORTED AFTER USING BD COR MX INSTRUMENT, THERE WAS 1 FALSE POSITIVE RESULT FOR THE TRICHOMONAS VAGINALIS PANEL. CONFIRMATORY TESTING WAS PERFORMED ON THE BD MAX, WHERE THE RESULT WAS NEGATIVE. AFTER OBSERVING THE BD COR GRAPHS, THE CUSTOMER DISCOVERED THAT THE SAMPLE HAD JUST CROSSED THE THRESHOLD TO BE CALLED POSITIVE. NO ADVERSE IMPACT WAS REPORTED REGARDING THE PATIENT OR USER.

Description of Event or Problem · 0

IT WAS REPORTED AFTER USING BD COR MX INSTRUMENT, THERE WAS 1 FALSE POSITIVE RESULT FOR THE TRICHOMONAS VAGINALIS PANEL. CONFIRMATORY TESTING WAS PERFORMED ON THE BD MAX, WHERE THE RESULT WAS NEGATIVE. AFTER OBSERVING THE BD COR GRAPHS, THE CUSTOMER DISCOVERED THAT THE SAMPLE HAD JUST CROSSED THE THRESHOLD TO BE CALLED POSITIVE. NO ADVERSE IMPACT WAS REPORTED REGARDING THE PATIENT OR USER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1132331 BD COR¿ MX DNA-REAGENTS, NEISSERIA LSL BECTON DICKINSON & CO. (SPARKS) 00382904439897

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown